CIK 0000879169
- Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943136539
- Phone
- +1 302-498-6700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- 4 Grant or award EVP, Head of Tech. Operations acquired 4,649 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 37,568 shares (grant or award)
- 4 Grant or award EVP & Chief Medical Officer acquired 58,165 shares (grant or award)
- 4 Grant or award EVP, Human Resources acquired 22,141 shares (grant or award)
- 4 Grant or award Chairman / CEO acquired 66,899 shares (grant or award)
- 4 Grant or award Director acquired 974 shares (grant or award)
- 4 Grant or award Director acquired 358 shares (grant or award)
- 4 Grant or award Director acquired 363 shares (grant or award)
- 4 Shares withheld for taxes EVP, GM, Dermatology US gave up 537 shares (to pay taxes)
- 4 Planned sale EVP & General Manager US sold 19,807 shares at an average $67.69 ($1,340,656)
- 4 Planned sale EVP & General Counsel sold 599 shares at $69.99 ($41,924)
- 4 Planned sale EVP & General Counsel sold 14,069 shares at an average $74.07 ($1,042,136)
- 4 Grant or award EVP, Head of Tech. Operations acquired 10,552 shares (grant or award)
- 4 Grant or award EVP, Head of Incyte Intl acquired 6,331 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 82 · 1,628 filings